U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Hypoinsulinemia

MedGen UID:
852189
Concept ID:
C2748055
Disease or Syndrome
HPO: HP:0040216

Definition

A decreased concentration of insulin in the blood. [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • Hypoinsulinemia

Conditions with this feature

Obesity due to prohormone convertase I deficiency
MedGen UID:
318777
Concept ID:
C1833053
Disease or Syndrome
Proprotein convertase-1/3 deficiency is an autosomal recessive disorder characterized by neonatal severe generalized malabsorptive diarrhea and failure to thrive. As the disease progresses, additional endocrine abnormalities develop, including diabetes insipidus, growth hormone deficiency, primary hypogonadism, adrenal insufficiency, and hypothyroidism (summary by Wilschanski et al., 2014).
Maturity-onset diabetes of the young type 9
MedGen UID:
383033
Concept ID:
C2677132
Disease or Syndrome
Maturity-onset diabetes of the young (MODY) is a group of several conditions characterized by abnormally high levels of blood glucose, also called blood sugar. These forms of diabetes typically begin before age 30, although they can occur later in life. In MODY, elevated blood glucose arises from reduced production of insulin, which is a hormone produced in the pancreas that helps regulate blood glucose levels. Specifically, insulin controls how much glucose (a type of sugar) is passed from the blood into cells, where it is used as an energy source.\n\nThe different types of MODY are distinguished by their genetic causes. The most common types are HNF1A-MODY (also known as MODY3), accounting for 50 to 70 percent of cases, and GCK-MODY (MODY2), accounting for 30 to 50 percent of cases. Less frequent types include HNF4A-MODY (MODY1) and renal cysts and diabetes (RCAD) syndrome (also known as HNF1B-MODY or MODY5), which each account for 5 to 10 percent of cases. At least ten other types have been identified, and these are very rare.\n\nGCK-MODY is a very mild type of the condition. People with this type have slightly elevated blood glucose levels, particularly in the morning before eating (fasting blood glucose). However, affected individuals often have no symptoms related to the disorder, and diabetes-related complications are extremely rare.\n\nHNF1A-MODY and HNF4A-MODY have similar signs and symptoms that develop slowly over time. Early signs and symptoms in these types are caused by high blood glucose and may include frequent urination (polyuria), excessive thirst (polydipsia), fatigue, blurred vision, weight loss, and recurrent skin infections. Over time uncontrolled high blood glucose can damage small blood vessels in the eyes and kidneys. Damage to the light-sensitive tissue at the back of the eye (the retina) causes a condition known as diabetic retinopathy that can lead to vision loss and eventual blindness. Kidney damage (diabetic nephropathy) can lead to kidney failure and end-stage renal disease (ESRD). While these two types of MODY are very similar, certain features are particular to each type. For example, babies with HNF4A-MODY tend to weigh more than average or have abnormally low blood glucose at birth, even though other signs of the condition do not occur until childhood or young adulthood. People with HNF1A-MODY have a higher-than-average risk of developing noncancerous (benign) liver tumors known as hepatocellular adenomas.\n\nRCAD is associated with a combination of diabetes and kidney or urinary tract abnormalities (unrelated to the elevated blood glucose), most commonly fluid-filled sacs (cysts) in the kidneys. However, the signs and symptoms are variable, even within families, and not everyone with RCAD has both features. Affected individuals may have other features unrelated to diabetes, such as abnormalities of the pancreas or liver or a form of arthritis called gout.
Hypoinsulinemic hypoglycemia and body hemihypertrophy
MedGen UID:
480014
Concept ID:
C3278384
Disease or Syndrome
Hypoinsulinemic hypoglycemia and body hemihypertrophy is a rare, genetic, endocrine disease characterized by neonatal macrosomia, asymmetrical overgrowth (typically manifesting as left-sided hemihypertrophy) and recurrent, severe hypoinsulinemic (or hypoketotic hypo-fatty-acidemic) hypoglycemia in infancy, which results in episodes of reduced consciousness and seizures.
Tenorio syndrome
MedGen UID:
864147
Concept ID:
C4015710
Disease or Syndrome
Tenorio syndrome (TNORS) is characterized by overgrowth, macrocephaly, and impaired intellectual development. Some patients may have mild hydrocephaly, hypoglycemia, and inflammatory diseases resembling Sjogren syndrome (270150) (summary by Tenorio et al., 2014).

Professional guidelines

PubMed

Norgren J, Sindi S, Matton A, Kivipelto M, Kåreholt I
J Nutr 2023 Dec;153(12):3506-3520. Epub 2023 Sep 29 doi: 10.1016/j.tjnut.2023.09.016. PMID: 37778510
Zhukouskaya VV, Eller-Vainicher C, Shepelkevich AP, Dydyshko Y, Cairoli E, Chiodini I
J Endocrinol Invest 2015 Sep;38(9):941-50. Epub 2015 Apr 12 doi: 10.1007/s40618-015-0284-9. PMID: 25863666
Peters A, Kerner W
Exp Clin Endocrinol Diabetes 1995;103(4):213-8. doi: 10.1055/s-0029-1211353. PMID: 7584526

Recent clinical studies

Etiology

Guevara-Aguirre J, Peña G, Acosta W, Pazmiño G, Saavedra J, Soto L, Lescano D, Guevara A, Gavilanes AWD
Endocr Relat Cancer 2023 Oct 1;30(10) Epub 2023 Aug 14 doi: 10.1530/ERC-22-0402. PMID: 37428642
Papanas N, Ziegler D
Rev Diabet Stud 2015 Spring-Summer;12(1-2):48-62. Epub 2015 Aug 10 doi: 10.1900/RDS.2015.12.48. PMID: 26676661Free PMC Article
Ziegler D, Papanas N, Vinik AI, Shaw JE
Handb Clin Neurol 2014;126:3-22. doi: 10.1016/B978-0-444-53480-4.00001-1. PMID: 25410210
Elena JW, Steplowski E, Yu K, Hartge P, Tobias GS, Brotzman MJ, Chanock SJ, Stolzenberg-Solomon RZ, Arslan AA, Bueno-de-Mesquita HB, Helzlsouer K, Jacobs EJ, LaCroix A, Petersen G, Zheng W, Albanes D, Allen NE, Amundadottir L, Bao Y, Boeing H, Boutron-Ruault MC, Buring JE, Gaziano JM, Giovannucci EL, Duell EJ, Hallmans G, Howard BV, Hunter DJ, Hutchinson A, Jacobs KB, Kooperberg C, Kraft P, Mendelsohn JB, Michaud DS, Palli D, Phillips LS, Overvad K, Patel AV, Sansbury L, Shu XO, Simon MS, Slimani N, Trichopoulos D, Visvanathan K, Virtamo J, Wolpin BM, Zeleniuch-Jacquotte A, Fuchs CS, Hoover RN, Gross M
Cancer Causes Control 2013 Jan;24(1):13-25. Epub 2012 Oct 31 doi: 10.1007/s10552-012-0078-8. PMID: 23112111Free PMC Article
Rao RH
Am J Clin Nutr 1983 Sep;38(3):440-4. doi: 10.1093/ajcn/38.3.440. PMID: 6351588

Diagnosis

Ziegler D, Papanas N, Vinik AI, Shaw JE
Handb Clin Neurol 2014;126:3-22. doi: 10.1016/B978-0-444-53480-4.00001-1. PMID: 25410210
Bartke A
Cell Cycle 2008 Nov 1;7(21):3338-43. Epub 2008 Nov 15 doi: 10.4161/cc.7.21.7012. PMID: 18948730
Brun JF, Fedou C, Mercier J
Diabetes Metab 2000 Nov;26(5):337-51. PMID: 11119013
Mueckler M
Diabetes 1990 Jan;39(1):6-11. doi: 10.2337/diacare.39.1.6. PMID: 2210061
Felig P, Wahren J, Sherwin R, Hendler R
Diabetes 1976 Dec;25(12):1091-9. doi: 10.2337/diab.25.12.1091. PMID: 992227

Therapy

de Bartolomeis A, De Simone G, De Prisco M, Barone A, Napoli R, Beguinot F, Billeci M, Fornaro M
Mol Psychiatry 2023 Jul;28(7):2811-2825. Epub 2023 Apr 21 doi: 10.1038/s41380-023-02065-4. PMID: 37085712Free PMC Article
Laron Z, Werner H
Pediatr Endocrinol Rev 2020 Mar;17(Suppl 1):191-197. doi: 10.17458/per.vol17.2020.lw.insulinghpotentialoncogene. PMID: 32208563
Szkudelski T, Szkudelska K
Biomed Pharmacother 2018 May;101:579-584. Epub 2018 Mar 22 doi: 10.1016/j.biopha.2018.02.063. PMID: 29514131
Nagai N, Ito Y, Taga A
J Oleo Sci 2013;62(9):737-43. doi: 10.5650/jos.62.737. PMID: 24005018
Rao RH
Am J Clin Nutr 1983 Sep;38(3):440-4. doi: 10.1093/ajcn/38.3.440. PMID: 6351588

Prognosis

Norgren J, Sindi S, Matton A, Kivipelto M, Kåreholt I
J Nutr 2023 Dec;153(12):3506-3520. Epub 2023 Sep 29 doi: 10.1016/j.tjnut.2023.09.016. PMID: 37778510
Botushanov NP, Orbetzova MM
Folia Med (Plovdiv) 2009 Oct-Dec;51(4):12-7. PMID: 20232652
Gottschalk ME, Schatz DA, Clare-Salzler M, Kaufman DL, Ting GS, Geffner ME
Diabetes Care 1992 Oct;15(10):1273-6. doi: 10.2337/diacare.15.10.1273. PMID: 1425088
Jallut D, Golay A, Munger R, Frascarolo P, Schutz Y, Jéquier E, Felber JP
Metabolism 1990 Oct;39(10):1068-75. doi: 10.1016/0026-0495(90)90168-c. PMID: 2215253
Langer O, Damus K, Maiman M, Divon M, Levy J, Bauman W
Am J Obstet Gynecol 1986 Oct;155(4):711-6. doi: 10.1016/s0002-9378(86)80004-7. PMID: 3532796

Clinical prediction guides

Guevara-Aguirre J, Peña G, Acosta W, Pazmiño G, Saavedra J, Soto L, Lescano D, Guevara A, Gavilanes AWD
Endocr Relat Cancer 2023 Oct 1;30(10) Epub 2023 Aug 14 doi: 10.1530/ERC-22-0402. PMID: 37428642
Kinross KM, Montgomery KG, Mangiafico SP, Hare LM, Kleinschmidt M, Bywater MJ, Poulton IJ, Vrahnas C, Henneicke H, Malaterre J, Waring PM, Cullinane C, Sims NA, McArthur GA, Andrikopoulos S, Phillips WA
FASEB J 2015 Apr;29(4):1426-34. Epub 2014 Dec 30 doi: 10.1096/fj.14-262782. PMID: 25550458
Kim HS, Lee MS
Curr Mol Med 2009 Feb;9(1):30-44. doi: 10.2174/156652409787314471. PMID: 19199940
Rayfield EJ, Kelly KJ, Yoon JW
Diabetes 1986 Nov;35(11):1278-81. doi: 10.2337/diab.35.11.1278. PMID: 3530856
Felig P, Wahren J, Sherwin R, Hendler R
Diabetes 1976 Dec;25(12):1091-9. doi: 10.2337/diab.25.12.1091. PMID: 992227

Recent systematic reviews

de Bartolomeis A, De Simone G, De Prisco M, Barone A, Napoli R, Beguinot F, Billeci M, Fornaro M
Mol Psychiatry 2023 Jul;28(7):2811-2825. Epub 2023 Apr 21 doi: 10.1038/s41380-023-02065-4. PMID: 37085712Free PMC Article

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...